Moleculin Biotech Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.51 |
Market Cap |
$54.23 M |
Shares Outstanding |
45.19 M |
Public Float |
21.62 M |
Address |
5300 Memorial Drive Houston Texas 77007 United States |
Employees | - |
Website | http://www.moleculin.com |
Updated | 07/08/2019 |
Moleculin Biotech, Inc. is a clinical stage pharmaceutical company, which focuses on the development of oncology drug candidates. Its Annamycin product candidate helps in the treatment of relapsed or refractory acute myeloid leukemia. The company's preclinical small molecule portfolios focus on the modulation of hard-to-target tumor cell signaling mechanisms and the metabolism of tumors. |